These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 11297865)
1. Inhibitory effects of xanthones on platelet activating factor receptor binding in vitro. Jantan I; Juriyati J; Warif NA J Ethnopharmacol; 2001 May; 75(2-3):287-90. PubMed ID: 11297865 [TBL] [Abstract][Full Text] [Related]
2. In vitro inhibitory effect of rubraxanthone isolated from Garcinia parvifolia on platelet-activating factor receptor binding. Jantan I; Pisar MM; Idris MS; Taher M; Ali RM Planta Med; 2002 Dec; 68(12):1133-4. PubMed ID: 12494345 [TBL] [Abstract][Full Text] [Related]
3. Yangambin: a new naturally-occurring platelet-activating factor receptor antagonist: binding and in vitro functional studies. Castro-Faria-Neto HC; Bozza PT; Cruz HN; Silva CL; Violante FA; Barbosa-Filho JM; Thomas G; Martins MA; Tibiriçá EV; Noel F Planta Med; 1995 Apr; 61(2):101-5. PubMed ID: 7753913 [TBL] [Abstract][Full Text] [Related]
4. Xanthones from the bark of Garcinia merguensis. Nguyen LH; Vo HT; Pham HD; Connolly JD; Harrison LJ Phytochemistry; 2003 Jun; 63(4):467-70. PubMed ID: 12770600 [TBL] [Abstract][Full Text] [Related]
5. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets. Morrison WJ; Shukla SD J Pharmacol Exp Ther; 1989 Sep; 250(3):831-5. PubMed ID: 2550620 [TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum. Nordin N; Jalil J; Jantan I; Murad S Pharm Biol; 2012 Mar; 50(3):284-90. PubMed ID: 22103812 [TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of platelet-activating factor receptor binding antagonists from Biota orientalis. Yang HO; Suh DY; Han BH Planta Med; 1995 Feb; 61(1):37-40. PubMed ID: 7700989 [TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect of kaempferol against binding of platelet activating factor to its receptor]. Zang BX; Jin M; Wu W; Chen WM; Piao YZ; Li JR Zhongguo Zhong Yao Za Zhi; 2004 Aug; 29(8):789-91. PubMed ID: 15506296 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet-activating factor receptor binding by aporphine and phenanthrenoid alkaloids from Aromadendron elegans. Jantan I; Rafi IA; Jalil J Planta Med; 2001 Jul; 67(5):466-7. PubMed ID: 11488464 [TBL] [Abstract][Full Text] [Related]
10. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies. Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624 [TBL] [Abstract][Full Text] [Related]
11. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist. Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776 [TBL] [Abstract][Full Text] [Related]
12. A prenylated xanthone from Allanblackia floribunda. Nkengfack AE; Azebaze GA; Vardamides JC; Fomum ZT; van Heerden FR Phytochemistry; 2002 Jun; 60(4):381-4. PubMed ID: 12031429 [TBL] [Abstract][Full Text] [Related]
13. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides. Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926 [TBL] [Abstract][Full Text] [Related]
14. An antagonistic activity of etizolam on platelet-activating factor (PAF). In vitro effects on platelet aggregation and PAF receptor binding. Mikashima H; Takehara S; Muramoto Y; Khomaru T; Terasawa M; Tahara T; Maruyama Y Jpn J Pharmacol; 1987 Aug; 44(4):387-91. PubMed ID: 2890779 [TBL] [Abstract][Full Text] [Related]
15. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation. Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729 [TBL] [Abstract][Full Text] [Related]
16. Piperbetol, methylpiperbetol, piperol A and piperol B: a new series of highly specific PAF receptor antagonists from Piper betle. Zeng HW; Jiang YY; Cai DG; Bian J; Long K; Chen ZL Planta Med; 1997 Aug; 63(4):296-8. PubMed ID: 9270371 [TBL] [Abstract][Full Text] [Related]
17. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet. Terashita Z; Imura Y; Nishikawa K Biochem Pharmacol; 1985 May; 34(9):1491-5. PubMed ID: 2986648 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors. Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554 [TBL] [Abstract][Full Text] [Related]
19. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils. Koike H; Imanishi N; Natsume Y; Morooka S Eur J Pharmacol; 1994 Nov; 269(3):299-309. PubMed ID: 7895770 [TBL] [Abstract][Full Text] [Related]
20. Bakkenolide G, a natural PAF-receptor antagonist. Liao CH; Ko FN; Wu TS; Teng CM J Pharm Pharmacol; 1997 Dec; 49(12):1248-53. PubMed ID: 9466352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]